In accordance with the in vitro data, we did not observe differential EZH2 mRNA amounts comparing bladder carcinomas of the TCGA 2017 data set either showing high ARID1A mRNA levels or low ARID1A mRNA expression (Fig 4E). The gene discussed is EZH2; the disease is urinary bladder carcinoma.